In Vitro, In Silico, and In Vivo Analyses of Novel Aromatic Amidines against Trypanosoma cruzi
- PMID: 29203486
- PMCID: PMC5786784
- DOI: 10.1128/AAC.02205-17
In Vitro, In Silico, and In Vivo Analyses of Novel Aromatic Amidines against Trypanosoma cruzi
Abstract
Five bis-arylimidamides were assayed as anti-Trypanosoma cruzi agents by in vitro, in silico, and in vivo approaches. None were considered to be pan-assay interference compounds. They had a favorable pharmacokinetic landscape and were active against trypomastigotes and intracellular forms, and in combination with benznidazole, they gave no interaction. The most selective agent (28SMB032) tested in vivo led to a 40% reduction in parasitemia (0.1 mg/kg of body weight/5 days intraperitoneally) but without mortality protection. In silico target fishing suggested DNA as the main target, but ultrastructural data did not match.
Keywords: Chagas disease; arylimidamides; experimental chemotherapy; in vivo.
Copyright © 2018 American Society for Microbiology.
Figures



Similar articles
-
In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.Antimicrob Agents Chemother. 2016 Mar 25;60(4):2425-34. doi: 10.1128/AAC.01667-15. Print 2016 Apr. Antimicrob Agents Chemother. 2016. PMID: 26856830 Free PMC article.
-
In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi.Antimicrob Agents Chemother. 2014 Jul;58(7):4191-5. doi: 10.1128/AAC.01403-13. Epub 2014 Mar 3. Antimicrob Agents Chemother. 2014. PMID: 24590476 Free PMC article.
-
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection.Drug Des Devel Ther. 2017 Apr 3;11:1095-1105. doi: 10.2147/DDDT.S120618. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28435221 Free PMC article.
-
Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.Parasitol Res. 2018 Nov;117(11):3367-3380. doi: 10.1007/s00436-018-6084-3. Epub 2018 Sep 19. Parasitol Res. 2018. PMID: 30232605 Review.
-
Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015).Expert Opin Ther Pat. 2016 Sep;26(9):993-1015. doi: 10.1080/13543776.2016.1209487. Epub 2016 Jul 19. Expert Opin Ther Pat. 2016. PMID: 27376456 Review.
Cited by
-
Imidazole Derivatives as Promising Agents for the Treatment of Chagas Disease.Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02156-18. doi: 10.1128/AAC.02156-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30670432 Free PMC article.
-
Review on Experimental Treatment Strategies Against Trypanosoma cruzi.J Exp Pharmacol. 2021 Mar 31;13:409-432. doi: 10.2147/JEP.S267378. eCollection 2021. J Exp Pharmacol. 2021. PMID: 33833592 Free PMC article. Review.
-
Phenotypic investigation of 4-nitrophenylacetyl- and 4-nitro-1H-imidazoyl-based compounds as antileishmanial agents.Parasitology. 2022 Apr;149(4):490-495. doi: 10.1017/S0031182021002079. Epub 2022 Feb 3. Parasitology. 2022. PMID: 35109958 Free PMC article.
-
Differentiating Trypanosoma cruzi in a Host Mammalian Cell Imaged in Aqueous Liquid by Atmospheric Scanning Electron Microscopy.Microbiol Spectr. 2022 Feb 23;10(1):e0141321. doi: 10.1128/spectrum.01413-21. Epub 2022 Jan 5. Microbiol Spectr. 2022. PMID: 34985339 Free PMC article.
-
In Vitro and In Vivo Evaluation of an Adamantyl-Based Phenyl Sulfonyl Acetamide against Cutaneous Leishmaniasis Models of Leishmania amazonensis.Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01188-20. doi: 10.1128/AAC.01188-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 32928731 Free PMC article.
References
-
- World Health Organization. 2013. Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases. World Health Organization, Geneva, Switzerland.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous